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Virus infection elicits potent responses in all cells intended to contain virus spread before intervention
by the adaptive immune system. Central to this process is the virus-elicited production of type I in-
terferons (IFNs) and other cytokines. The sensors involved in coupling recognition of viruses to the
induction of the type I IFN genes have only recently been uncovered and include endosomal and
cytosolic receptors for RNA and DNA. Here, we review their properties and discuss how their ability
to recognize the unusual presence of atypical nucleic acids in particular subcellular compartments is
used by the body to detect virus presence.Many immunologists think about immune responses to vi-
rus infection in terms of production of neutralizing anti-
bodies and induction of cytotoxic activity in T lymphocytes
and natural killer (NK) cells. Although these are clearly es-
sential for immunity to viruses that have coevolved with
vertebrates (Hedrick, 2004), there are other layers of anti-
viral defense that operate independently of lymphocytes
or NK cells. All metazoan cells possess intrinsic mecha-
nisms to prevent viral replication and spread. In inverte-
brates such as Drosophila melanogaster, a prominent an-
tiviral resistance mechanism is RNA interference (RNAi)
(Galiana-Arnoux et al., 2006; Wang et al., 2006). In verte-
brates, the RNAi pathway is preserved, but its role in
antiviral defense appears to have been superseded by
a panoply of other mechanisms (Cullen, 2006). These
include intrinsic immunity proteins such as Fv or tripartite
motif protein (TRIM) 5a, which target capsids of incoming
retroviruses, as well as Mx proteins, which target nucleo-
proteins of bunya- and orthomyxoviruses, and apolipo-
protein B mRNA-editing enzyme catalytic polypeptide-
like editing complex (APOBEC) 3G, which deaminates
retroviral genomes, causing mutations that impair subse-
quent virus replication (Bieniasz, 2004; Haller et al., 2007)
(Figure 1). In addition, vertebrate cells possess antiviral
mechanisms that are not constitutively active but can be
rapidly mobilized by viral presence (Samuel, 2001). For
example, viral RNAs activate the kinases protein kinase
R (PKR) and/or general control nonderepressible-2
(GCN2), which phosphorylate the a subunit of the transla-
tion initiator factor 2 (eIF2a), leading to the downregulation
of mRNA translation (Berlanga et al., 2006; Williams,
2001). Similarly, viral RNA leads to activation of the 20-50
oligoadenylate synthetase (20-50 OAS), which activates
RNase L, promoting RNA degradation (Player and
Torrence, 1998). Finally, infection triggers the activity of
adenosine deaminase acting on RNA (ADAR)-1, which
deaminates RNA viral replication intermediates (Samuel,
2001) (Figure 1).
The shutdown of protein translation, RNA degradation,
and RNA deamination are detrimental to cell viability
and can result in induction of apoptosis (Samuel, 2001)370 Immunity 27, September 2007 ª2007 Elsevier Inc.(Figure 1). Therefore, it is critical that such antiviral re-
sponses only be activated in infected cells. This inducibility
implies that all cells possess sensitive, yet specific mech-
anisms to sense viral presence. In other words, there must
be receptors and signaling pathways used to distinguish
viral patterns from self. In that sense, PKR, GCN2, 20-50
OAS, ADAR-1, and other initiators of antiviral immunity
(Figure 1) can all be seen as pattern recognition receptors
(PRRs) (Janeway, 1989) for viral RNA. However, the term
PRR is generally reserved for those receptors that signal
to regulate the transcriptome, for example, inducing ex-
pression of proinflammatory cytokines and chemokines
that coordinate innate and adaptive immunity (Janeway,
1989). Multiple cytokines are induced by virus infection,
including interleukin-6 (IL-6), IL-12 p40, and tumor necro-
sis factor (TNF), but the hallmark of antiviral responses is
the production of type I interferons (IFNs). Type I IFNs in-
clude multiple subtypes encoded by separate intronless
genes: 1 IFN-b and 13-14 IFN-a subtypes, depending on
species, as well as the lesser-known IFN-3, IFN-k, IFN-u,
IFN-d, IFN-t, and IFN-z (Pestka et al., 2004). In contrast
to type II IFN (IFN-g), which is made predominantly by
T lymphocytes and NK cells in response to T cell receptor
(TCR) or NK cell receptor signals, type I IFNs can be pro-
duced by all nucleated cells in response to virus infection.
In addition, all cells can respond to type I IFNs through the
type I IFN receptor (IFNAR), which binds all subtypes (Stark
et al., 1998). Recently, a distinct class of virus-induced
IFNs has been identified. These are known as the type III
IFNs and include IFN-l1, IFN-l2, and IFN-l3, which are
encoded by separate intron-containing genes (Kotenko
et al., 2003). The type I, II, and III IFNs all signal via different
receptors but share downstream signaling molecules and
regulate many of the same genes (Stark et al., 1998). Stud-
ies of mice and humans lacking the signal transducer and
activator of transcription 1 (STAT1), a signaling molecule
common to all IFN receptors, have revealed that respon-
siveness to IFNs is absolutely critical for antiviral resistance
(Dupuis et al., 2003; Durbin et al., 1996). This is because
a major function of IFNs is to increase the expression of
the eIF2a kinases, 20-50 OAS, ADAR1, Mx, APOBEC, Fv,
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ReviewFigure 1. Innate Immunity to Viruses
Innate responses to viral infection can be focused on viral proteins or viral nucleic acids. Viral proteins are targeted by cytoplasmic restriction factors
such as Fv (mouse), TRIM-5a (human), or Mx proteins. Viral nucleic acids trigger PKR, GCN2, and other kinases that phosphorylate eIF2a, which
results in the downregulation of translation. In addition, viral RNA stimulates 20-50OAS to activate RNase L, resulting in the unspecific degradation
of RNA. Both PKR and 20-50OAS can additionally signal for the induction of apoptosis. Finally, viral RNA is targeted by the deaminases ADAR1
and APOBEC3G, leading to mutations in viral genomes. Viral nucleic acids and, perhaps, some viral proteins also activate TLRs, RLRs, and DAI
to initiate a signaling cascade that promotes activation of IRFs and transcription of IFN-a and -b genes. IFN-a and -b feed back through IFNAR to
increase expression of antiviral proteins, thereby amplifying antiviral resistance.and TRIM proteins (Samuel, 2001; Stark et al., 1998) (Fig-
ure 1). This, in turn, leads to induction of a heightened
antiviral state and underlies the discovery of IFNs as virus
interference factors 50 years ago (Isaacs and Lindenmann,
1957). In addition, IFNs act to stimulate NK cells, to amplify
dendritic cell (DC) activation, and to facilitate the induction
of adaptive immune responses (Le Bon and Tough, 2002)
(Figure 1). Therefore, justifiably, the search for receptors
and signaling pathways involved in the innate sensing of vi-
ruses has centered on those that culminate in transcription
of the IFN-a, -b, and -l genes. In recent years, there has
been rapid progress in this field, and viral PRRs are now
known to include members of the toll-like receptor (TLR)
family, which also recognizes patterns found in bacteria,
fungi, and protozoa (Takeda et al., 2003), and retinoic
acid inducible gene I (RIG-I), melanoma differentiation fac-
tor-5 (MDA5), laboratory of genetics and physiology-2
(LGP-2), and DNA-dependent activator of IRFs (DAI), all
cytosolic proteins which have evolved specifically to sense
viruses (Takaoka et al., 2007; Yoneyama and Fujita, 2007).
Here, we review our current state of understanding of these
innate receptors for viruses and how they function in
discriminating virus from self.Receptors and Signaling Pathways Involved
in Type I IFN Induction
Virus Sensing in the Cytosol
Many viruses carry out their entire infectious cycle in the
cytosol, but even viruses such as influenza, which repli-
cate in the nucleus, traverse the cytosol on their way in
and out of the cell. Accordingly, cells possess receptors
and signaling pathways to induce IFN-a, -b, and -l gene
expression in response to cytosolic viral presence. Nota-
bly, the genes encoding the cytosolic viral PRRs and the
components of the downstream signaling pathway are
themselves IFN inducible, like those of other antiviral pro-
teins, leading to a positive-feedback loop that can greatly
amplify innate antiviral responses (Figure 1).
It has long been thought that this loop is set in motion by
the presence of double-stranded RNA (dsRNA) in cells.
dsRNA fulfills the criteria for being a marker of virus infec-
tion: Long dsRNA molecules are absent from uninfected
cells but can be formed by the complementary annealing
of two strands of RNA produced during the replication of
RNA viruses and as a result of the convergent transcription
of tightly packed DNA virus genomes (Jacobs and Lang-
land, 1996). The first cytoplasmic molecule reported toImmunity 27, September 2007 ª2007 Elsevier Inc. 371
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was the serine and threonine kinase PKR (Williams,
2001). In some studies, cells lacking functional PKR pro-
duced lower amounts of IFN-a and -b when treated with
polyriboinosinic:polyribocytidylic acid (poly I:C), a syn-
thetic dsRNA (Der and Lau, 1995; Diebold et al., 2003;
Yang et al., 1995). However, this was not the case in re-
sponse to infection with Newcastle disease virus (NDV)
(Honda et al., 2003; Smith et al., 2001) or influenza virus
(unpublished data). Furthermore, although PKR can
promote the activation of nuclear factor kappa B (NF-kB)
(Kumar et al., 1994), its ability to activate interferon regula-
tory factors (IRF) 3 and 7, the critical transcription factors in
induction of IFN-a and -b via the cytosolic pathway (see
below), has yet to be convincingly demonstrated. There-
fore, the role of PKR in the induction of type I IFN remains
controversial.
RIG-I was recently identified as an IFN-inducible DExD/
H box RNA-helicase that can signal for IRF3 and IRF7 ac-
tivation and for the induction of IFN-a, -b, and -l gene ex-
pression (Onoguchi et al., 2007; Yoneyama et al., 2004).
RIG-I is a cytosolic protein containing an RNA-binding
helicase domain and two caspase activation and recruit-
ment domains (CARDs). The helicase domain has an
ATP-binding site, which, when mutated, results in a loss-
of-function phenotype and dominant negative activity
(Yoneyama et al., 2004). RIG-I lacking the CARD domains
or bearing mutated CARDs also acts as a dominant nega-
tive protein (Yoneyama et al., 2004). Notably, the CARDs
of RIG-I are ubiquitinated by the TRIM25 E3 ligase, a mod-
ification that is critical for downstream signaling and type I
IFN induction (Gack et al., 2007). In contrast, ubiquitina-
tion by another E3 ligase, RNF125, promotes the protea-
somal degradation of RIG-I and termination of signaling
(Arimoto et al., 2007). Recently, it has been shown that
a C-terminal domain within RIG-I acts as an internal re-
pressor of activation (Saito et al., 2007), leading to the
notion that RIG-I agonists induce protein multimerization
and cause a conformational change that relieves auto-
repression and exposes the CARDs (Figure 2).
Two other poly I:C-binding proteins belong to the RIG-I-
like receptor (RLR) family (Creagh and O’Neill, 2006):
MDA5 and LGP-2 (Rothenfusser et al., 2005; Yoneyama
et al., 2005). Like RIG-I, MDA5 bears an RNA-helicase do-
main and two CARDs, but it lacks the C-terminal repres-
sion domain and, consequently, induces the production
of IFN-a and -b upon overexpression (Saito et al., 2007).
However, in uninfected cells, the ability of MDA5 to couple
to the IRF3 pathway is under negative regulation by dihy-
droxyacetone kinase (Diao et al., 2007). In contrast, LGP-2
lacks CARDs and blocks IFN-a and -b induction, much like
the RIG-I helicase domain, which it resembles (Rothen-
fusser et al., 2005; Yoneyama et al., 2005). Therefore,
LGP-2 has been thought to act as a negative regulator
of the two other helicases, a notion that might need revis-
iting in light of recent analysis of LGP-2-deficient cells
(see below).
The discovery of RLRs was rapidly followed by the
identification of the downstream adaptor, interferon-b372 Immunity 27, September 2007 ª2007 Elsevier Inc.promoter stimulator-1 (IPS-1), also called mitochondrial
antiviral signaling protein (MAVS), CARD adaptor inducing
IFN-b (CARDIF), or virus-induced signaling adaptor (VISA)
(Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005;
Xu et al., 2005). IPS-1 contains an N-terminal CARD that
forms homotypic interactions with the CARDs of RIG-I
and MDA5. This results in activation of the C-terminal cat-
alytic domain and the initiation of a signaling cascade that
culminates in the transcription of cytokine genes. In partic-
ular, IPS-1, together with TNF receptor-associated factor
(TRAF) 3 and NAK-associated protein 1 (NAP1), promotes
the activation of members of the IkB kinase (IKK) family,
namely TANK-binding kinase 1 (TBK-1) and IKK3 (Hacker
et al., 2006; Kawai et al., 2005; Kumar et al., 2006; Meylan
et al., 2005; Oganesyan et al., 2006; Sasai et al., 2006;
Seth et al., 2005; Sun et al., 2006; Xu et al., 2005). The lat-
ter phosphorylate and activate IRF7 and/or IRF3 (Fitzger-
ald et al., 2003; Sharma et al., 2003), which induce the
transcription of the IFN-a and IFN-b genes (Honda et al.,
2005b). IPS-1 also associates with the adaptor Fas-
associated death domain (FADD) and the kinases receptor-
interacting protein 1 (RIP1), transforming growth factor
b-activated kinase 1 (TAK1), IKKa, and IKKb to mediate
the activation of NF-kB and mitogen-activated protein ki-
nase (MAPK) pathways (Balachandran et al., 2004; Taka-
hashi et al., 2006). This is important for transcription of the
gene encoding IFN-b, whose promoter, unlike the pro-
moters of the Ifna genes, contains NF-kB and activating
protein 1 (AP-1) sites in addition to the IRF sites (Honda
et al., 2006). Interestingly, IPS-1 is anchored to mitochon-
dria through its C terminus, and the disruption of this asso-
ciation abrogates signaling (Seth et al., 2005) (Figure 2).
The association with mitochondria and signaling through
FADD, both of which are involved in apoptosis, suggests
a possible crosstalk between IFN-a and -b induction and
cell death (Balachandran et al., 2004; Takahashi et al.,
2006).
Given that both RIG-I and MDA5 bind poly I:C and signal
via a common pathway, it was unclear whether they
played redundant roles in recognition of viruses. The gen-
eration of MDA5- and RIG-I-deficient mice demonstrated
a remarkable specificity for the two helicases (Gitlin et al.,
2006; Kato et al., 2006). RIG-I-deficient cells were found to
mount greatly diminished IFN-a and -b responses to influ-
enza A virus, vesicular stomatitis virus (VSV), Japanese
encephalitis virus (JEV), and Sendai virus (SeV) (Kato
et al., 2006), whereas MDA5-deficient cells were selec-
tively unresponsive to picornaviruses, such as encephalo-
myocarditis virus (EMCV), Theiler’s encephalomyelitis
virus, and mengovirus (Gitlin et al., 2006; Kato et al.,
2006). Interestingly, the two helicases also differentially af-
fected responses to synthetic dsRNA: IFN-a and -b induc-
tion in response to poly I:C was abrogated in cells lacking
MDA5 (Gitlin et al., 2006; Kato et al., 2006), whereas RIG-I-
deficient cells did not respond to a set of dsRNAs made by
annealing complementary ssRNAs generated by in vitro
transcription (Kato et al., 2006). Thus, RIG-I and MDA5 ap-
pear to recognize patterns from different RNA viruses.
This distinction might not be absolute because responses
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ReviewFigure 2. Pathways Coupling Virus
Recognition to IFN-a and -b Gene
Expression
There are two topologically distinct compart-
ments within cells in which viruses can be rec-
ognized by PRRs that then signal to induce
IFN-a and -b gene transcription. Endosomal
pathway: The uptake of viruses or virus-
infected cells delivers viral nucleic acids into
endosomes, where they are detected by
TLRs. In pDC, TLR7, 8, and 9 signal via the
adaptor MyD88 and the kinase IKKa to phos-
phorylate and activate the transcription factor
IRF7, which regulates expression of the IFN-
a and IFN-b genes; in cDC, TLR9 and MyD88
couple to IRF1 but not IRF7, resulting in the ex-
pression of IFN-b. TLR3 signals via TRIF, which
couples to the kinases TBK-1 and IKK3 and
phosphorylates IRF3 to induce IFN-a and/or
-b. Cytosolic pathway: Viral RNAs are recog-
nized by MDA5 and RIG-I, which signal via
the mitochondrion-associated adaptor IPS-1.
IPS-1 activates the kinases TBK-1 and IKK3
to phosphorylate IRF3 and IRF7 and induce
IFN-a and -b gene transcription. Cytosolic
DNA receptor(s) such as DAI use an alternative
adaptor to couple to TBK-1 and IKK3, and IRF3
and IRF7. Note that the endosomal and cyto-
solic pathways also couple to NF-kB and
MAPK activation, which is important for the ex-
pression of the IFN-b gene and regulates the
expression of numerous other proinflammatory
cytokines and chemokines (not depicted).
Note also that there is likely to be extensive
crosstalk between the endosomal and cyto-
solic pathways (depicted by arrows): Nucleic
acids can ‘‘leak’’ from endosomes to activate cytosolic PRRs, whereas autophagy can provide cytosolic nucleic acids for endosomal recognition.
The following abbreviations and labels are used: leucine-rich repeat (LRR), Toll/IL-1Receptor signaling domain (TIR), caspase activating recruitment
domain (CARD), RNA-binding domain (Helicase); RD: repressor domain (RD), Z-DNA binding domains (Za, Zb), tentatively named region required for
DNA binding (D3), and signaling domain (SD).to JEV and SeV are decreased to a variable extent by
MDA5 deficiency (Diao et al., 2007; Kato et al., 2006), sug-
gesting that some viruses might be recognized by both
MDA5 and RIG-I.
RIG-I can bind poly I:C and polyriboadenylic:polyribour-
idylic acid (poly A:U), another synthetic dsRNA, (Rothen-
fusser et al., 2005; Yoneyama et al., 2005) but is not
activated by either (Gitlin et al., 2006; Kato et al., 2006), in-
dicating that RNA binding to RLRs is not sufficient for ag-
onist activity. The critical determinant in RIG-I stimulation
by RNA was recently identified as the presence of phos-
phates at the 50 end independently of single or double
strandedness (Hornung et al., 2006; Pichlmair et al.,
2006). This has provided a partial explanation for the virus
specificity of RIG-I. Thus, the RNA genomes of influenza,
rabies virus, and VSV are single stranded but possess 50
triphosphates and therefore can bind RIG-I and promote
its activation (Hornung et al., 2006; Pichlmair et al.,
2006). Similarly, in vitro transcribed RNA used to make
dsRNA (Kato et al., 2006) bears a triphosphate on the first
ribonucleotide (Hornung et al., 2006; Kim et al., 2004). In
contrast, commercial poly I:C does not generally contain
free triphosphates and does not normally activate RIG-I.
Notably, the 50 phosphate requirement also explains why
RIG-I does not mediate responses to picornaviruses
whose genomes are covalently linked at the 50 end toa viral protein that acts as a primer for replication
(Racaniello, 2001).
The ability of RIG-I to recognize single-stranded RNA
(ssRNA) of viral origin challenges the dogma that antiviral
responses all rely on the recognition of dsRNA and is con-
sistent with the observation that the replication of negative
ssRNA viruses leads to potent IFN responses yet is not ac-
companied by the formation of immunodetectable dsRNA
(Pichlmair et al., 2006; Weber et al., 2006). Ironically, some
of the first investigations into the inducibility of IFN-a
and -b had employed ssRNA (Isaacs et al., 1963), although
this was later abandoned in favor of the double-stranded
version. This is not to say that double strandedness has
no role: Intrastrand hybridization clearly contributes to
RIG-I recognition, as noted for secondary structures pres-
ent on the hepatitis C virus (HCV) genome (Saito et al.,
2007). However, the notion that linear molecules of viral
RNA can contain all the necessary attributes to activate
IFN-a and -b responses means that innate detection
need not be linked to the generation of complementary
RNAs, and explains how viral entry into the cytoplasm
can sometimes induce IFN-a and -b responses in the ab-
sence of viral replication (Collins et al., 2004; Hidmark
et al., 2005; Isaacs and Lindenmann, 1957). It is important
to note that we still do not know which viral RNAs are
actually sensed by RIG-I during infection. Influenza virusImmunity 27, September 2007 ª2007 Elsevier Inc. 373
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mental setting, but it is difficult to envisage how this might
happen during infection when the genome segments are
coated by viral nucleoprotein and have the viral polymer-
ase bound to their 50 ends (Lamb and Krug, 2001). Further-
more, influenza virus uncoating and replication takes
place in the nucleus, a location not subject to surveillance
by RIG-I. Therefore, one might expect that RIG-I senses in
the influenza virus cycle an RNA intermediate that bears
a 50 phosphate and becomes cytoplasmic during infec-
tion. Consistent with this notion, during measles infection,
RIG-I is activated by gene products that are transcribed
early in the virus life cycle (Plumet et al., 2007).
In contrast to RIG-I, the agonist for MDA5 remains un-
characterized. Picornaviruses produce abundant dsRNA
during cell infection (Pichlmair et al., 2006; Weber et al.,
2006), and MDA5 could therefore act simply as a dsRNA
sensor, as per the dsRNA dogma. Consistent with this no-
tion, MDA5 binds to and is activated by poly I:C (Gitlin
et al., 2006; Kato et al., 2006; Rothenfusser et al., 2005;
Yoneyama et al., 2005). However, MDA5 does not com-
pensate for RIG-I deficiency in the response to in vitro-
transcribed dsRNA (Kato et al., 2006), indicating that its
activation requires more than RNA double strandedness.
Notably, among the dsRNA homopolymers, only commer-
cial poly I:C of undefined length induces a potent IFN-
a and -b response (unpublished data). Therefore, poly
I:C, rather than generic dsRNA, mimics the MDA5 agonist
generated during picornavirus infection.
The role of the third member of the RLR family remains
elusive at present. Consistent with an inhibitory role, cells
from mice lacking LGP-2 show enhanced production of
IFN-a and -b in response to poly I:C treatment or VSV in-
fection (Venkataraman et al., 2007). However, IFN-b pro-
duction after EMCV infection is actually impaired by
LGP-2 deficiency (Venkataraman et al., 2007). Therefore,
LGP-2 might play both a positive and negative role in
responses initiated by the other two helicases.
RNA has been the focus of much attention, but it is not
the only nucleic acid that can elicit IFN-a and -b produc-
tion. Despite thousands of man-years worth of DNA trans-
fections, it was only recently noticed that the introduction
of the B helical form of dsDNA into the cytoplasm leads
to IFN-a and -b induction (Ishii et al., 2006; Okabe et al.,
2005; Stetson and Medzhitov, 2006; Yasuda et al.,
2005). The cytosolic dsDNA-sensing pathway converges
with the RLR pathway at the point of TBK-1 and IKK3 ac-
tivation (Ishii et al., 2006; Stetson and Medzhitov, 2006)
but does not require the activity of IPS-1, at least in the
mouse (Kumar et al., 2006; Sun et al., 2006). One candi-
date cytosolic dsDNA sensor has recently emerged as
the IFN-inducible protein DLM-1 or Z-DNA binding protein
1, now renamed DAI for DNA-dependent activator of IRFs
(Takaoka et al., 2007). The binding of DAI to dsDNA in-
creases its ability to interact with TBK-1 and IRF3, and
the overexpression of DAI in cells potentiates the re-
sponse to DNA transfection, whereas the knockdown of
endogenous DAI decreases it (Takaoka et al., 2007). It is
widely expected that the DNA-sensing pathway will be374 Immunity 27, September 2007 ª2007 Elsevier Inc.involved in the detection of DNA viruses and bacteria
that access the cytoplasmic compartment.
Virus Sensing in Endosomes
Most viruses encounter the endocytic pathway on their
way in and out of cells, either because they infect cells
via endosomes or because they bud into those compart-
ments after the completion of their replication cycle (Bran-
denburg and Zhuang, 2007). Accordingly, a subset of
TLRs appears to be dedicated to surveying endosomes
for viral presence. The endosomal TLRs all share the prop-
erty of being activated by nucleic acids and include TLR3,
TLR7, TLR8, and TLR9 (Figure 2). Their expression can be
increased by IFN-a and -b, much like that of RLRs and
DAI, but endosomal TLRs have a more restricted cellular
distribution. TLR7 and 9 are highly expressed by DCs
and, in humans but not mice, by principally those of the
plasmacytoid subset (pDC), but can also be expressed
by other hematopoietic cells, such as B cells (Iwasaki
and Medzhitov, 2004; Reis e Sousa, 2004). TLR3 is ex-
pressed more widely, including on nonhematopoietic
cells, but it shows preferential expression in nonplasma-
cytoid (conventional) DCs (cDCs) (Iwasaki and Medzhitov,
2004; Reis e Sousa, 2004). Less is known about TLR8,
which, in the mouse, may be nonfunctional or have a non-
immune role (Jurk et al., 2002; Ma et al., 2006). Notably,
although TLR3, 7, and 9 recognize viral agonists in endo-
somes, the bulk of the receptors at any given time is found
in the endoplasmic reticulum in association with the 12
transmembrane spanning protein Unc93b (Latz et al.,
2004) (Brinkmann et al., 2007; Tabeta et al., 2006). The lat-
ter plays an essential role in responses mediated by all the
endosomal TLRs, possibly by regulating their recruitment
to endosomes (Brinkmann et al., 2007; Casrouge et al.,
2006; Tabeta et al., 2006).
All TLRs can signal for the activation of NF-kB and
MAPK cascades and promote the transcription of multiple
cytokine and chemokine genes, but endosomal TLRs
have additional pathways to activate IRF1, 3, or 7 and in-
duce IFN-a and -b expression. TLR3 signals via the adap-
tor TRIF, which can activate the TBK-1 and IKK3 kinases
together with TRAF3 and NAP1, much like IPS-1 (Uematsu
and Akira, 2007). This allows TLR3 to couple to the IRF3
pathway in a manner similar to the RLRs and DAI (Figure 2).
In contrast, TLR7 and 9 use a different adaptor, MyD88.
The pathways coupling MyD88 to type I IFN gene induc-
tion have been studied mostly in the context of TLR9 sig-
naling. TLR9 can be activated by ssDNA oligonucleotides
containing unmethylated CpG motifs (Krieg, 2002; Latz
et al., 2007). Such oligonucleotides (CpG DNA) induce
type I IFN production by pDC through a pathway involving
MyD88, IRAK1, and TRAF6 (Uematsu and Akira, 2007).
This leads to the activation of IKKa, which, in this setting,
substitutes for TBK-1 or IKK3 in phosphorylating and acti-
vating IRF7 (Hoshino et al., 2006) (Figure 2). In cell types
other than pDCs, this pathway is not operative, and
TLR9 (or TLR7) stimulation only couples to the activation
of NF-kB and MAPK, leading to production of cytokines
such as IL-6 or IL-12 but not IFN-a. The fact that TLR9
(and TLR7) signaling induces IFN-a only in pDCs has led
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amounts of type I IFNs when, in fact, cDCs and other
cell types also produce large amounts of IFN-a and IFN-
b through the activation of the cytosolic virus-sensing
pathway (Diebold et al., 2003). In addition, mouse cDCs
produce IFN-b but not IFN-a in response to TLR9 stimula-
tion through a pathway dependent on IRF1 rather than
IRF3 or IRF7 (Figure 2) (Negishi et al., 2006; Schmitz
et al., 2007). Therefore, the defining feature of pDCs is
the ability to couple TLR9 and TLR7 signaling to IFN-a
gene expression, rather than an ontogenetically deter-
mined ability to produce high levels of type I IFNs. Why
pDCs couple TLR9 activation to IRF7 whereas cDCs cou-
ple the same receptor to IRF1 remains poorly understood,
but it might reflect the differential use of cofactors such as
osteopontin (Shinohara et al., 2006) and/or the markedly
different endosomal routing of CpG in the two cell types.
Indeed, the ability of pDC to produce IFN-a in response
to TLR9 signaling correlates with their ability to retain
CpG DNA in an early endosomal compartment (Guiducci
et al., 2006; Honda et al., 2005a).
Perhaps because the specialized endosomal traffic in
pDCs has evolved to maximize TLR-mediated responses
to incoming viruses, these cells have been useful in defin-
ing the role of TLR9 and TLR7 in virus recognition. Thus,
TLR9 allows pDCs to respond to DNA viruses such as ad-
enovirus, herpes simplex virus (HSV)-1 and -2 or murine
cytomegalovirus (MCMV) (Hochrein et al., 2004; Iaco-
belli-Martinez and Nemerow, 2007; Krug et al., 2004a;
Krug et al., 2004b; Lund et al., 2003). Similarly, TLR7 me-
diates pDC responses to ssRNA viruses such as influenza,
VSV, and Sendai virus (Diebold et al., 2004; Lund et al.,
2004) and to genomic ssRNA purified from influenza vi-
rions or synthetic ssRNA oligonucleotides containing U
or GU repeats (Diebold et al., 2004; Diebold et al., 2006;
Heil et al., 2004). The latter can also act as agonists for hu-
man TLR8 (Heil et al., 2004). Together, these observations
have led to a model in which viruses are taken up by pDCs
(or other cells) and are subjected to proteolytic degrada-
tion in the endosomal compartment, exposing their RNA
or DNA genomes for recognition by TLR7, 8, or 9 (Crozat
and Beutler, 2004). The process is independent of infec-
tion, thereby allowing responses to viruses that do not
normally replicate in DCs, as well as to defective viral par-
ticles or inactive viruses. The latter could be particularly
relevant during infection because viruses neutralized by
antibody or complement can be taken up via Fc or com-
plement receptors, thereby potentiating TLR stimulation
within endosomes (Wang et al., 2007). Such a mechanism
could be especially important to allow the endosomal
recognition of viruses that fuse at the plasma membrane.
It should be said that there is at present no in vivo evi-
dence that virus recognition by TLR7 and TLR9 operates
as per this model. Therefore, it is possible that the actual
role of TLR recognition is not in detecting extracellular vi-
rus sampled from the external milieu but, perhaps, prog-
eny virions as they bud from the cell or even captured frag-
ments of lysed cells bearing viral particles. An unexpected
role for endosomal TLR recognition in viral infection hasbeen found recently, whereby autophagy in pDC allows
capture of VSV RNA replication intermediates from the
cytosol and recognition via TLR7 (Lee et al., 2007). Auto-
phagosomes fuse with endosomes, effectively bridging
the endosomal compartment to the cytosol. Therefore,
through autophagy, endosomal TLRs are no longer
restricted to sampling the extracellular compartment
and can contribute to cytosolic recognition of viruses
(Figure 2).
It has been argued that pDCs rely on TLR-mediated rec-
ognition of viruses, whereas other cells such as cDCs use
the cytosolic pathway (Kato et al., 2005). This is not en-
tirely correct; cDCs can use TLR7 and/or 9 to recognize vi-
ruses even if this does not result in IFN-a production (see
above). Conversely, it is possible that pDCs can use the
cytosolic pathway, but this has not been observed in all
studies because pDCs are difficult to infect. Notably,
Myd88/ pDCs defective in TLR7 and 9 signaling behave
like cDCs in that they do not produce IFN-a in response to
infection with wild-type influenza virus but do so upon in-
fection with a mutant lacking the NS1 viral protein, which,
if present, blocks RIG-I activation (see below) (Diebold
et al., 2004). Similarly, Tlr9/ pDCs from murine bone
marrow (although not pDCs from spleen) produce IFN-a
and -b in response to HSV-1 (Hochrein et al., 2004), and
human pDCs produce IFN-a in response to respiratory
syncytial virus (RSV) via a cytosolic rather than an endoso-
mal pathway (Hornung et al., 2004). On the other hand,
TLR7-deficient murine pDCs do not respond to VSV, per-
haps because a high rate of autophagy in those cells
sequesters viral RNAs from RIG-I and MDA5 (Lee et al.,
2007).
TLR3 is the final member of the endosomal TLR family,
although it can also be expressed at the plasma mem-
brane in some cell types (Matsumoto et al., 2002). It was
originally identified as a receptor for dsRNA on the basis
of its ability to mediate responses to poly I:C and to puri-
fied reoviral dsRNA (Alexopoulou et al., 2001; Matsumoto
et al., 2002). More recently, it has been reported that TLR3
also responds to poly I (Marshall-Clarke et al., 2007), rais-
ing the question of whether (as for MDA5) it is truly and
simply a receptor for dsRNA. CD14 has been shown to fa-
cilitate poly I:C uptake and TLR3 activation (Lee et al.,
2006), but the role of TLR3 might not be in recognizing ex-
ogenous naked dsRNA, which is unlikely to be found as
a free-floating species in the extracellular milieu. Rather,
TLR3 might act like TLR7 and 9 in recognizing incoming vi-
ruses, such as reoviruses, which have a dsRNA genome,
or, through autophagy, it might recognize dsRNA pro-
duced by viruses replicating in the cytosol. An additional
scenario in which TLR3 has been implicated is in the
recognition by DCs of phagocytosed virus-infected cells
containing dsRNA (Schulz et al., 2005).
In summary, there is a striking parallel between the
cytoplasmic and endosomal pathways for the innate sens-
ing of viruses (Figure 2). They both recognize DNA, ssRNA,
and dsRNA and signal via parallel pathways for induction
of IFN-a and -b. This suggests that the innate immune
system focuses on viral nucleic acids as an invariantImmunity 27, September 2007 ª2007 Elsevier Inc. 375
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we use the same determinants for virus classification.
Virus Sensing at the Cell Surface?
In addition to the endosomal TLRs, TLR2 and TLR4 have
also been suggested to play a role in sensing of viruses.
These TLRs are expressed at the cell surface but can be
recruited to the endocytic compartment by internalized li-
gands (Underhill et al., 1999). TLR2 signaling does not
couple to IFN-a and -b induction, although TLR4 does
so via the TRIF pathway (Uematsu and Akira, 2007).
TLR2 has been shown to respond to components of mea-
sles, HCV, MCMV, and HSV (Bieback et al., 2002) (Comp-
ton et al., 2003; Duesberg et al., 2002; Kurt-Jones et al.,
2004), whereas TLR4 can respond to RSV, retroviruses,
and coxsackie B virus (Kurt-Jones et al., 2000; Rassa
et al., 2002; Richer et al., 2006). However, when examined
closely, the TLR2 and 4 dependence of virus recognition is
often restricted to a few virus isolates (Sato et al., 2006). In
addition, many examples of TLR2 and TLR4 ‘‘recognition’’
involve viral surface proteins. These often mutate in order
to escape adaptive immune recognition by antibodies
(Hangartner et al., 2006), so it is hard to envisage why
they would not do so to escape TLR recognition. Interest-
ingly, the ability of measles virus to activate TLR2 maps to
a single amino acid on the viral hemagglutinin, and this
amino acid is preserved in wild-type but not in vaccine
strains, suggesting that the wild-type virus actively targets
TLR2 (Bieback et al., 2002). Similarly, the analysis of
mouse mammary tumor virus infection in TLR4-sufficient
and -deficient mice indicates that the virus targets TLR4
to replicate in B cells and to suppress CTL responses
(Jude et al., 2003; Rassa et al., 2002). Therefore, some ex-
amples of TLR engagement by viruses represent viral ex-
ploitation of the TLR system rather than the innate sensing
of viruses (Rassa and Ross, 2003).
Innate Discrimination between Viral
and Self Nucleic Acids
The innate recognition pathways described above are ex-
quisitely sensitive to the presence of viral nucleic acids but
are generally silent in the absence of infection. However,
the reasons for this robust virus versus self discrimination
are still not fully understood. Clearly, some viral nucleic
acids have features of PAMPs, which allow for the distinc-
tion of potential pathogens from the host (Janeway, 1989).
For example, the 50 triphosphate on many ssRNAs of viral
origin is absent from mRNA, which bears a 50 methyl-
guanosine cap (Alberts et al., 2002) that does not allow
RIG-I activation (Hornung et al., 2006). A 50 triphosphate
is also absent from transfer RNA (tRNA), which, although
uncapped, is processed to yield a 50 monophosphate
(Alberts et al., 2002). However, a 50 triphosphate is found
on 5S ribosomal RNA (rRNA), an abundant species of
cellular RNA. Why this does not lead to RIG-I activation
is unclear, but it might have to do with the fact that the
50 end of the rRNA is obscured by ribosomal proteins
(Ramakrishnan, 2002). A similar argument applies to the
7S RNA component of the signal recognition particle,
which also contains a 50 triphosphate (Wild et al., 2002).376 Immunity 27, September 2007 ª2007 Elsevier Inc.In addition, rRNA, tRNA, and other structural RNAs are
heavily modified by conversion of uridine to pseudouri-
dine, 2-thiouridine, and 2-O-methyluridine, all of which de-
crease RIG-I stimulatory activity when incorporated into 50
triphosphate RNA oligonucleotides (Hornung et al., 2006).
Finally, as discussed above, RIG-I binding and activation
can also be favored by structural elements that are more
prevalent in viral RNAs, such as the panhandle structures
at the 50 ends of influenza genomic RNA segments (Lamb
and Krug, 2001) or the untranslated portions of the HCV
genome (Saito et al., 2007).
These considerations highlight the fact that innate rec-
ognition of viruses is not as simple as the recognition of
bacterial PAMPs such as LPS. Strictly speaking, there
are no viral PAMPs because, to some extent, they are all
shared by the host. In some cases, this could actually be
used to amplify antiviral immunity: A recent report sug-
gests that RNase L activation in virus-infected cells gener-
ates small self RNAs that potentiate the activation of RIG-I
and MDA5 (Malathi et al., 2007) (Figure 1). Therefore, there
is no absolute sense in which the innate immune system
can be said to discriminate virus from self. The robustness
of innate responses to viral infection appears to come
from coupling sensing of quantitative differences in prev-
alence of certain patterns, e.g., high abundance of un-
modified uridine in viral genomes, to another important
parameter, that of abnormal localization. For example,
the cytosolic pathway effectively relies on the principle
that certain species of nucleic acids are only found in
the nucleus. The cytosolic presence of DNA or 50 triphos-
phate-bearing RNA must therefore reflect an abnormal
situation, such as virus infection, that requires response.
Nowhere is the importance of localization better exem-
plified than in TLR-mediated virus recognition. As for the
cytosolic pathway, there is a quantitative component to
endosomal TLR activation in that the dearth of CpG motifs
in self DNA or the presence of modified uridine in self RNA
raise the threshold for TLR9 or 7 activation, respectively
(Kariko´ et al., 2005; Latz et al., 2007). However, this is
not sufficient for absolute discrimination, as indicated by
the fact that the increased delivery of self DNA or self
mRNA to endosomes can lead to TLR9 or 7 activation
(Diebold et al., 2006; Lau et al., 2005; Leadbetter et al.,
2002). Most notably, the mislocalization of TLR9 to the
plasma membrane allows it to respond to self DNA pres-
ent in the extracellular space (Barton et al., 2006). In other
words, the TLRs involved in viral nucleic acid recogni-
tion are restricted to endosomes because self DNA and
self RNA have limited access to those compartments
(Marshak-Rothstein and Rifkin, 2007).
In this scenario, the biggest challenge to self versus vi-
rus discrimination is the clearance of apoptotic cells. It is
perhaps no coincidence that phagocytes taking up apo-
ptotic cells, including macrophages and, in the mouse,
the CD8a+ subset of cDC, do not express TLR7 (Reis e
Sousa, 2004). It is also perhaps so that innate responses
can be diminished that DNA degradation is initiated in
cells undergoing apoptosis and is completed in the phag-
olysosomes of scavenger cells (Nagata, 2005). Notably,
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tion via the cytoplasmic pathway, resulting in autoimmu-
nity (Kawane et al., 2006; Okabe et al., 2005; Yoshida
et al., 2005). In addition, defects in apoptotic cell clear-
ance are often associated with systemic lupus erythema-
tosus (SLE) or other autoimmune diseases (Gaipl et al.,
2005). This suggests that the system is carefully titrated
to deal with the normal load of apoptotic cells and that
phagocytic scavengers rapidly dispose of cell corpses
before secondary necrosis allows the release of internal
nucleic acids. It further suggests that although phago-
cytes can be alerted to the presence of viruses within dy-
ing cells (Schulz et al., 2005), they have efficient pathways
to avoid responding to nucleic acids within uninfected
apopotic bodies, through lack of sensors and/or the pres-
ence of active nucleases. Changes in this balance, by the
increase of apoptotic cell load, the decrease of clearance
or digestion by scavengers, or the increase of innate
detection [e.g., through TLR7 duplication (Pisitkun et al.,
2006)] can allow antiviral detection mechanisms to begin
to react to self, often with devastating consequences.
Innate Sensing Pathways in Resistance
to Viral Infection
With multiple pathways for virus sensing, an important
question is to what extent they are redundant for protec-
tion from viral infection. The availability of mice in which
single TLRs, RLRs, or downstream signaling components
have been genetically ablated offers an opportunity to ad-
dress this question. Tlr3/ mice do not show increased
susceptibility to infection with VSV, LCMV, or reovirus
(Edelmann et al., 2004; Johansson et al., 2007) and
show either unchanged or only slightly lower resistance
to MCMV (Edelmann et al., 2004; Tabeta et al., 2004). Nev-
ertheless, a role for TLR3 has been found in the regulation
of immunopathology associated with infection. For in-
stance, Tlr3/ mice are paradoxically more resistant to
infection with lethal doses of West Nile virus because
TLR3 contributes to the inflammatory response to the
virus, resulting in leakiness of the blood-brain barrier and
allowing the infection of the brain (Wang et al., 2004). Sim-
ilarly, in a mouse model of acute pneumonia induced by
influenza virus, the lack of TLR3 promotes increased sur-
vival despite higher virus titers in the lungs (Le Goffic et al.,
2006). Finally, Tlr3/ mice are also more resistant to
infection with Punta Toro virus, perhaps because TLR3
deficiency restricts production of proinflammatory media-
tors, such as IL-6, which contribute to immunopathology
(Gowen et al., 2006).
The role of TLR9 in responses to DNA viruses is also un-
settled. TLR9-, MyD88-, or Unc93b-deficient mice show
greater mortality and increased virus titers in response
to MCMV infection, in part because of a role of the TLR9
and MyD88 pathway in promoting cytokine production,
leading to the activation of NK cells (Krug et al., 2004a;
Tabeta et al., 2004; Tabeta et al., 2006). TLR9 is also im-
portant for protection from intravaginal HSV-2 infection,
mediating early production of IFN-a and -b by locally
recruited pDCs and thereby limiting virus spread (Lundet al., 2006). However, TLR9 or MyD88 are not required
for protection from HSV-1 infection in a footpad injection
or corneal scarification model (Krug et al., 2004b). The
susceptibility of Tlr7/ mice to infection has not been
analyzed although MyD88-deficient mice are susceptible
to intranasal infection with VSV (Zhou et al., 2007), a virus
that is recognized in part via TLR7.
The lack of a consistent role for individual TLRs in pro-
tection from viral infection should not come as a surprise
given the more restricted distribution of these receptors
compared to the RLR family, the possibility of redundancy
among distinct TLRs, and the overlap between the endo-
somal and cytosolic pathways (Figure 2). However, the lat-
ter might be a lot less redundant: Preliminary evidence in-
dicates that RIG-I-deficient mice are highly susceptible to
infection with JEV, whereas mice lacking MDA5 succumb
to EMCV as early as those lacking IFNAR (Kato et al.,
2006). Similarly, LGP2-deficient mice show enhanced
susceptibility to EMCV (Venkataraman et al., 2007).
The experimental infection of mice is a highly contrived
situation that does not mimic exposure to natural inoculat-
ing routes and virus doses and is markedly affected by ge-
netic background, including the absence of certain antivi-
ral pathways in most inbred mouse strains (Pichlmair et al.,
2004). In contrast, analysis of primary immunodeficiencies
in patients is more informative in determining the relative
importance of innate recognition pathways in human pop-
ulations naturally exposed to the repertoire of human
viruses. So far, patients lacking IRAK4 have been found
to possess normal resistance to viruses even though
they cannot couple TLR7 and 9 recognition to IFN-a and
-b or IFN-l induction (Yang et al., 2005). Similarly, patients
with an autosomal recessive defect in UNC93B are resis-
tant to most viral infections, although they suffer from
sporadic HSV encephalitis (Casrouge et al., 2006). Thus,
the TLR pathway might be dispensable for responses to
many viruses in human populations. Patients with defects
in the cytosolic pathway have not been reported.
Viral Evasion of Innate Immunity
Viruses have to multiply extensively in infected hosts to
ensure successful transmission, a challenging task in the
face of immune attack. Therefore, it is not surprising that
viruses that infect vertebrates have developed a myriad
of immune evasions strategies, a significant number of
which target the IFN system. Viruses can inhibit IFN-
a and -b synthesis, inactivate secreted IFN molecules, in-
terfere with IFNAR signaling, and/or block the activation of
antiviral effector proteins upregulated by IFNs (Weber
et al., 2004). Here, we focus exclusively on the strategies
used by viruses to block the PRR pathways discussed
above.
A number of viruses might inhibit IFN-a and -b induction
by sequestering viral agonists from PRRs. For example,
escape from cytosolic recognition could be accomplished
by replication within membrane-bound compartments
known as virus factories (Novoa et al., 2005). Other viruses
encode dsRNA-binding proteins, such as the vaccinia vi-
rus E3L protein, which are believed to prevent IFN-a andImmunity 27, September 2007 ª2007 Elsevier Inc. 377
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Notably, E3L also possesses a DNA-binding site (Kim
et al., 2003), raising the possibility that it might additionally
sequester viral DNA from the DAI recognition pathway.
The nonstructural protein 1 (NS1) of some strains of influ-
enza virus also possesses a dsRNA-binding site and was
thought to inhibit IFN-a and -b production through dsRNA
sequestration (Garcia-Sastre, 2001). However, this site
also allows binding to ssRNA and the formation of a com-
plex with RIG-I in the presence of 50 triphosphate RNA
(Pichlmair et al., 2006). This suggests that the NS1 protein
might in fact block IFN-a and -b induction by targeting
RIG-I (Guo et al., 2007; Mibayashi et al., 2007; Opitz
et al., 2007; Pichlmair et al., 2006), although it might also
use additional mechanisms, some of which are virus-
strain specific (Kochs et al., 2007).
Like influenza virus, other viruses may inhibit IFN-a and
-b induction through targeting PRRs or downstream sig-
naling molecules. The V proteins of paramyxoviruses
can block MDA5 activation (Andrejeva et al., 2004), per-
haps explaining why Sendai virus is recognized primarily
via the RIG-I pathway (Kato et al., 2006). The NS3-4A pro-
tein of HCV can cleave both IPS-1 and TRIF, thereby an-
tagonizing both the RLR and TLR3 pathway (Foy et al.,
2005; Li et al., 2005; Meylan et al., 2005). Similarly, vac-
cinia virus A52R protein interferes with TLR signaling
(Harte et al., 2003). Finally, several viruses belonging to
different classes have been reported to interfere with the
activation of IRF3, suggesting either direct interaction
with IRFs or inhibition of upstream kinases (Weber et al.,
2004).
In sum, viruses target the IFN system at multiple points
of the innate response, including blocking IFN-a and
-b gene induction. Viruses that have lost their ability to
block the IFN system have reduced pathogenicity and
are often used as vaccine strains in experimental model
systems. However, it should be noted that suppression
of the IFN system by viruses is never as severe as, for ex-
ample, that seen upon experimental ablation of IFNAR or
the STAT proteins. This might reflect the coevolution of
virus and host, leading to an equilibrium that preserves
both organisms.
Conclusion
In 1957, Isaacs and Lindenmann reported the discovery
of IFNs (Isaacs and Lindenmann, 1957). In the 50 years
since, much has been learned about IFN receptor signal-
ing and IFN-dependent antiviral immunity. However, the
molecular mechanisms coupling detection of viruses to
induction of the IFN-a and -b genes have only recently
begun to be understood. The vertebrate strategy for the
innate sensing of viruses is similar to that used for
detection of bacteria and fungi and relies on detection of
PAMP-like nucleic acids prevalent in viruses. However,
because such nucleic acids are, to a greater or lesser
extent, also found in the host, sensing virus presence
requires an additional strategy. Hence, a fundamental
aspect of innate recognition of viruses is to monitor the378 Immunity 27, September 2007 ª2007 Elsevier Inc.presence of nucleic acids in locations where the self
equivalents are not normally found.
The compartmentalization of innate recognition of vi-
ruses has interesting parallels in the strategy used by the
adaptive immune system. Both systems employ special-
ized molecules to survey the two cellular compartments
where potential pathogens might be found. TLRs and
MHC class II molecules sample the endosomal compart-
ment, whereas RLRs, DAI, and MHC class I perform an
analogous function in the cytosol. RLRs and MHC class I
are ubiquitously expressed by all nucleated cells, whereas
MHC class II and endosomal TLRs have a more restricted
distribution, primarily in immune cells. Like MHC mole-
cules, virus PRRs can be upregulated by exposure to
IFN-a and -b and/or IFN-g. Finally, the two systems are
separate but in constant communication. The delivery of
endosomal contents to the cytoplasm allows both MHC
class I crosspresentation and RLR or DAI activation. Con-
versely, autophagy provides cytoplasmic proteins for
MHC class II presentation (Deretic, 2006) and viral nucleic
acids for TLR recognition. The notion that innate pathogen
recognition and MHC presentation are intimately related is
further suggested by the observation that Unc93b con-
trols both endosomal TLR delivery and crosspresentation
(Tabeta et al., 2006) and that TLR signaling can regulate
MHC class II presentation (Blander and Medzhitov, 2006).
The membrane biology aspects of immune recognition
and of viral infection are therefore fertile ground for future
discoveries. The next fifty years of IFN research might be
marked by the intimate merging of innate immunity and
cell biology research.
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